Article info

Download PDFPDF

Short report
Evaluation of response to 13-valent conjugated pneumococcal vaccination in patients with rheumatoid arthritis receiving upadacitinib: results from a phase 2 open-label extension study

Authors

  1. Correspondence to Dr Kevin Winthrop; winthrop{at}ohsu.edu
View Full Text

Citation

Winthrop K, Vargas JI, Drescher E, et al
Evaluation of response to 13-valent conjugated pneumococcal vaccination in patients with rheumatoid arthritis receiving upadacitinib: results from a phase 2 open-label extension study

Publication history

  • Received November 15, 2021
  • Accepted January 30, 2022
  • First published March 4, 2022.
Online issue publication 
March 04, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.